Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding Poseida Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 116 | 2 | 2 | −112 |
| Shares | 54.1M | 419.3K | 100.0K | −53.6M (−99.8%) |
| Value | $519.2M | $4.03M | $308.0K | −$514.9M (−99.9%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Poseida Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
None.
Sold out (112)
Institutions that held Poseida Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
Showing the largest 100 of 112 by value.
Not filed for Q1 2025 yet (2)
Institutions that held Poseida Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 299,297 | $2.87M |
| Cigogne Management SA | 120,000 | $1.15M |